226 related articles for article (PubMed ID: 27880666)
1. The current management landscape: aspergillosis.
Maertens JA; Blennow O; Duarte RF; Muñoz P
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii23-ii29. PubMed ID: 27880666
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.
Ahmad S; Khan ZU; Theyyathel AM
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):165-71. PubMed ID: 17574786
[TBL] [Abstract][Full Text] [Related]
4. Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?
Buchheidt D; Reinwald M; Spiess B; Boch T; Hofmann WK; Groll AH; Lehrnbecher T;
Mycoses; 2016 Feb; 59(2):67-74. PubMed ID: 26756571
[TBL] [Abstract][Full Text] [Related]
5. Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.
Neofytos D; Railkar R; Mullane KM; Fredricks DN; Granwehr B; Marr KA; Almyroudis NG; Kontoyiannis DP; Maertens J; Fox R; Douglas C; Iannone R; Kauh E; Shire N
PLoS One; 2015; 10(6):e0129022. PubMed ID: 26107507
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
7. Detection of Aspergillus fumigatus-specific DNA, (1-3)-beta-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats.
Khan ZU; Ahmad S; Theyyathel AM
Mycoses; 2008 Mar; 51(2):129-35. PubMed ID: 18254749
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit.
Talento AF; Dunne K; Joyce EA; Palmer M; Johnson E; White PL; Springer J; Loeffler J; Ryan T; Collins D; Rogers TR
J Crit Care; 2017 Aug; 40():119-127. PubMed ID: 28384600
[TBL] [Abstract][Full Text] [Related]
9. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
10. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study.
Boch T; Reinwald M; Spiess B; Liebregts T; Schellongowski P; Meybohm P; Rath PM; Steinmann J; Trinkmann F; Britsch S; Michels JD; Jabbour C; Hofmann WK; Buchheidt D
J Crit Care; 2018 Oct; 47():198-203. PubMed ID: 30015290
[TBL] [Abstract][Full Text] [Related]
11. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
13. Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosis.
Zhao Y; Paderu P; Railkar R; Douglas C; Iannone R; Shire N; Perlin DS
Med Mycol; 2016 Nov; 54(8):801-7. PubMed ID: 27335056
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis.
Ahmad S; Al-Shaikh AA; Khan Z
PLoS One; 2014; 9(6):e100524. PubMed ID: 24955575
[TBL] [Abstract][Full Text] [Related]
15. Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.
Petraitiene R; Petraitis V; Bacher JD; Finkelman MA; Walsh TJ
Med Mycol; 2015 Aug; 53(6):558-68. PubMed ID: 26129890
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients.
Badiee P; Alborzi A; Karimi M; Pourabbas B; Haddadi P; Mardaneh J; Moieni M
J Infect Dev Ctries; 2012 Apr; 6(4):352-7. PubMed ID: 22505446
[TBL] [Abstract][Full Text] [Related]
17. Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.
Schwarzinger M; Sagaon-Teyssier L; Cabaret O; Bretagne S; Cordonnier C;
PLoS One; 2013; 8(6):e65776. PubMed ID: 23799048
[TBL] [Abstract][Full Text] [Related]
18. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.
McCulloch E; Ramage G; Rajendran R; Lappin DF; Jones B; Warn P; Shrief R; Kirkpatrick WR; Patterson TF; Williams C
J Clin Pathol; 2012 Jan; 65(1):83-6. PubMed ID: 22049217
[TBL] [Abstract][Full Text] [Related]
19. The performance of galactomannan in combination with 1,3-β-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: Evidences from 13 studies.
Zhang L; Guo Z; Xie S; Zhou J; Chen G; Feng J; Huang Y
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):44-53. PubMed ID: 30279025
[TBL] [Abstract][Full Text] [Related]
20. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
